These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

261 related items for PubMed ID: 12233982

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Pharmacotherapy: Quest for the quitting pill.
    Willyard C.
    Nature; 2015 Jun 25; 522(7557):S53-5. PubMed ID: 26107096
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Pathological gambling: focusing on the addiction, not the activity.
    Tamminga CA, Nestler EJ.
    Am J Psychiatry; 2006 Feb 25; 163(2):180-1. PubMed ID: 16449466
    [No Abstract] [Full Text] [Related]

  • 8. Naltrexone treatment of self-injurious behavior.
    Godart NT, Agman G, Perdereau F, Jeammet P.
    J Am Acad Child Adolesc Psychiatry; 2000 Sep 25; 39(9):1076-8. PubMed ID: 10986803
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Opioid antagonists in broadly defined behavioral addictions: a narrative review.
    Piquet-Pessôa M, Fontenelle LF.
    Expert Opin Pharmacother; 2016 Sep 25; 17(6):835-44. PubMed ID: 26798982
    [Abstract] [Full Text] [Related]

  • 11. Naltrexone treatment of dementia with severe self-injurious behaviors: a single case study.
    Vance HB, Kauffmann C, Pumariega AJ, Del Mundo A.
    Psychiatry; 2000 Sep 25; 63(3):288-99. PubMed ID: 11125673
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Topiramate in substance-related and addictive disorders].
    Cohen J, Dervaux A, Laqueille X.
    Presse Med; 2014 Sep 25; 43(9):892-901. PubMed ID: 25027463
    [Abstract] [Full Text] [Related]

  • 14. Anticraving medications for relapse prevention: a possible new class of psychoactive medications.
    O'Brien CP.
    Am J Psychiatry; 2005 Aug 25; 162(8):1423-31. PubMed ID: 16055763
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. A risk-benefit assessment of naltrexone in the treatment of alcohol dependence.
    Berg BJ, Pettinati HM, Volpicelli JR.
    Drug Saf; 1996 Oct 25; 15(4):274-82. PubMed ID: 8905252
    [Abstract] [Full Text] [Related]

  • 17. Naltrexone: a controversial therapy for alcohol dependence.
    Freed PE, York LN.
    J Psychosoc Nurs Ment Health Serv; 1997 Jul 25; 35(7):24-8. PubMed ID: 9243420
    [Abstract] [Full Text] [Related]

  • 18. Evidence about the use of naltrexone and for different ways of using it in the treatment of alcoholism.
    Sinclair JD.
    Alcohol Alcohol; 2001 Jul 25; 36(1):2-10. PubMed ID: 11139409
    [Abstract] [Full Text] [Related]

  • 19. Pharmacologic treatments for drug and alcohol dependence.
    Kranzler HR, Amin H, Modesto-Lowe V, Oncken C.
    Psychiatr Clin North Am; 1999 Jun 25; 22(2):401-23. PubMed ID: 10385941
    [Abstract] [Full Text] [Related]

  • 20. Treatment of obsessive-compulsive cutting behavior with naltrexone.
    Bystritsky A, Strausser BP.
    J Clin Psychiatry; 1996 Sep 25; 57(9):423-4. PubMed ID: 9746454
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.